Duration of efficacy of Ty21a, attenuated Salmonella typhi live oral vaccine (Q40632057)

22 September 2017

Duration of efficacy of Ty21a, attenuated Salmonella typhi live oral vaccine (English)

1 reference

22 September 2017

Salmonella typhi

1 reference

Levine MM

1

1 reference

22 September 2017

Ferreccio C

2

1 reference

22 September 2017

Abrego P

3

1 reference

22 September 2017

Martin OS

4

1 reference

22 September 2017

Ortiz E

5

1 reference

22 September 2017

Cryz S

6

1 reference

22 September 2017

language of work or name

English

0 references

publication date

1 October 1999

1 reference

22 September 2017

1 reference

22 September 2017

17 Suppl 2

1 reference

22 September 2017

S22-7

1 reference

Isolation and Characterization of Gal E Mutant Ty 21a of Salmonella typhi: A Candidate Strain for a Live, Oral Typhoid Vaccine

22 September 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900231-5

7 January 2021

Large-scale field trial of Ty21a live oral typhoid vaccine in enteric-coated capsule formulation

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900231-5

7 January 2021

Efficacy of one or two doses of Ty21a Salmonella typhi vaccine in enteric-coated capsules in a controlled field trial. Chilean Typhoid Committee

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900231-5

7 January 2021

Comparative efficacy of two, three, or four doses of TY21a live oral typhoid vaccine in enteric-coated capsules: a field trial in an endemic area

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900231-5

7 January 2021

Comparison of enteric-coated capsules and liquid formulation of Ty21a typhoid vaccine in randomised controlled field trial

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900231-5

7 January 2021

Oral immunisation against typhoid fever in Indonesia with Ty21a vaccine

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900231-5

7 January 2021

Impact of age and drug resistance on mortality in typhoid fever

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900231-5

7 January 2021

Therapeutic aspects of typhoidal salmonellosis in childhood: the Karachi experience

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900231-5

7 January 2021

Multidrug-resistant typhoid fever in children: epidemiology and therapeutic approach.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900231-5

7 January 2021

Community-acquired septicaemia in southern Viet Nam: the importance of multidrug-resistant Salmonella typhi

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900231-5

7 January 2021

Short courses of ofloxacin for the treatment of enteric fever

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900231-5

7 January 2021

Quinolone-resistant Salmonella typhi in Vietnam

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900231-5

7 January 2021

Quinolone-resistant Salmonella typhi in Viet Nam: molecular basis of resistance and clinical response to treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900231-5

7 January 2021

Antibiotic-multiresistant Salmonella typhi in Egypt.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900231-5

7 January 2021

Win-win interactions between the public and private sectors

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900231-5

7 January 2021

Progress in vaccines against typhoid fever

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900231-5

7 January 2021

A seven-year field trial of two typhoid vaccines in Guyana

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900231-5

7 January 2021

Immunogenicity, efficacy and serological correlate of protection of Salmonella typhi Vi capsular polysaccharide vaccine three years after immunization

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900231-5

7 January 2021

Protective activity of Vi capsular polysaccharide vaccine against typhoid fever

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900231-5

7 January 2021

Persistence of antibody titres three years after vaccination with Vi polysaccharide vaccine against typhoid fever

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900231-5

7 January 2021

10.1016/S0264-410X(99)00231-5

Identifiers

DOI

1 reference

release_2dgd6lecfvfkzi5fd43nfshz4e

22 September 2017

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/2dgd6lecfvfkzi5fd43nfshz4e

24 November 2022

mapped directly with Wikidata item

1 reference